Tony Muhlenkamp hosted a chat with our portfolio managers Ron and Jeff Muhlenkamp. During the conversation, Ron and Jeff shared their review of 2017, a year with unusually low market volatility, record-high market levels, and expensive equity valuations. They provided charts and checklists to better explain consumer and business spending and optimism, inflation, investors’ margin accounts, and many other items they monitor to determine where the economy is at year end and what concerns them going into 2018. They also explained how actions of the Japanese and European central banks may be influencing the U.S. stock market. More >
Jeff Muhlenkamp, Portfolio Manager, summarizes the economy using his 10-point checklist. Also, to celebrate our 40th anniversary, we asked Ron Muhlenkamp, Portfolio Manager, to reflect on lessons he has learned and changes he has seen since he founded Muhlenkamp & Company in 1977. Included are Ron’s insights and observations. More >
When it comes to building our portfolios, we say we build them from the bottom up and then we edit them from the top down. During the Muhlenkamp & Company webcast on Thursday, May 11, 2017, Portfolio Manager Jeff Muhlenkamp along with President Tony Muhlenkamp shared our process. Jeff also talked about some of the key indicators that we are following to give investors an insight into what we are doing and why. More >
Ron's maxim, “When you change the rules a little, you change the game a lot,”
applies to many things in life. During our webcast, Jeff and Ron looked at the potential impact and the second and third effects that changing policies and regulations by President Trump and his new administration could have on the economy. Since the last recession, small businesses have been reluctant to expand because they were unsure of the rules: the possibility of increased taxes, expanding healthcare costs, and more regulations. After the 2016 election, small business confidence spiked. Jeff and Ron debated what may have boosted optimism. They also talked about current interest rates, bond rates, the dollar, and ongoing concerns in Europe.
Is the economy back to pre-recessionary levels? Your answer may depend on what data you use and how you define your terms. Jeff and Ron walk through over 20 economic charts from foreign currencies vs. the dollar to their 10-point checklist they use as a guide. Here is an archive or our December 1, 2016 webinar.
Ron addresses how the retirement plans of individuals and institutions have changed due to low GDP growth, productivity, and interest rates—what was thought to be temporary has lasted longer than expected, with no end in sight. The assumptions made while making retirement plans and decisions ten years ago are now obsolete. Jeff summarizes the implications for investors of every age and disposition.
Portfolio managers Ron and Jeff presented their observations, interpretations, and decisions about the investment climate. They updated us on the items comprising their “checklist,” ranging from what’s happening on the domestic front (interest rates, consumer spending, health of financial institutions, etc.) to what’s taking place across the globe (Europe, China, emerging markets, etc.). More >
In this country, a quarter of our natural gas production is used by industry, a quarter is used to generate electricity, and half is used for home heating. As investors, we learned a long time ago that if a product or service makes sense to the consumer it probably will last a long time. More >
The financial headlines tell us the stock market is hitting new highs, but they don’t tell us much about what is going on beneath the surface. Ron and Jeff Muhlenkamp talk about some of the cross currents in the global markets and economies because we think future returns will depend on what you own, when you bought it, and what you paid to get it—owning an index, industry or sector will be less useful. To us, that’s the very definition of A Stock Picker’s Market. More >
Advances in biomedical science continue to transform the way medicine is being practiced. Since the 1950s, we have experienced a steady stream of breakthrough innovations, ranging from vaccines for the masses to precision medicines based on one’s unique genetic makeup. In a 50-year span, we’ve gone from characterizing the double-helix structure of DNA to a complete mapping of the human genome. More >